亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

OnabotulinumtoxinA Injections for Patients with Chronic Migraine During the COVID-19 Pandemic

作者
Samer Narouze
标识
DOI:10.30756/ahmj.2020.02.06
摘要

Headaches are among the top prevalent conditions that physicians encounter in their daily practice. Migraine headaches affect nearly15% of the United States population (approximately 45 million).‎‎1,‎2 Over 50% of all patients with migraine report significant or severe impairment and disability.2 Migraine is the leading cause of years lived with disability among patients between ages 15 and 49 years old – the most productive years.‎‎3 According to the World Health Organization headache report, up to 4% of the world’s population experience chronic migraine (headaches occurring on at least 15 days per month with at least 8 of these headaches meeting migraine criteria).‎‎‎4 Approximately, 65% of patients with episodic migraine and 75% of patients with chronic migraine have missed family events and activities in the past month due to migraine-related impairment.‎‎5 Migraine also significantly impacts work-related activities. It has been estimated that 11% of patients with chronic migraine have been missing at least 1 day of work per week in the past 2 weeks‎.‎‎6 Based on migraine attack frequency and related disability, headache experts suggest offering prophylactic treatment options to patients with four migraine attacks per month or more. ‎‎7 Nevertheless, it has been estimated that only 26-29% of patients continue to adhere to their prophylactic treatment regimen at 6 months and only 17-20% continue to use their oral preventive medications at 12 months. ‎8,‎9 OnabotulinumtoxinA injection is an established FDA-approved therapy for chronic migraine prevention.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
复杂的士萧完成签到 ,获得积分10
5秒前
6秒前
9秒前
10秒前
卉卉完成签到,获得积分10
13秒前
林xq完成签到 ,获得积分10
14秒前
愉快的泥猴桃完成签到 ,获得积分10
16秒前
黄黄胖胖的龙完成签到,获得积分10
16秒前
标致访旋完成签到,获得积分10
18秒前
22秒前
23秒前
23秒前
NinjiaQiu完成签到 ,获得积分10
25秒前
25秒前
李李发布了新的文献求助10
27秒前
28秒前
清脆世界完成签到 ,获得积分10
29秒前
青柳雅春发布了新的文献求助10
29秒前
动听问旋完成签到,获得积分10
33秒前
醉熏的小小完成签到 ,获得积分10
35秒前
35秒前
39秒前
落后裙子完成签到,获得积分10
40秒前
Clover04的应助被海绵宝宝采纳,获得10
43秒前
乐迪发布了新的文献求助10
45秒前
Ren的应助被落后裙子采纳,获得100
45秒前
45秒前
青柳雅春完成签到,获得积分10
48秒前
得财完成签到,获得积分20
49秒前
Maestro_S的应助被科研通管家采纳,获得10
51秒前
Maestro_S的应助被科研通管家采纳,获得10
52秒前
52秒前
CAOHOU的应助被科研通管家采纳,获得10
52秒前
52秒前
无花果的应助被科研通管家采纳,获得10
52秒前
风吹麦浪的应助被科研通管家采纳,获得10
52秒前
大模型的应助被或大或小采纳,获得10
54秒前
55秒前
cyanpomelo完成签到,获得积分10
56秒前
57秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184991
求助须知:如何正确求助?哪些是违规求助? 9573924
关于积分的说明 21833782
捐赠科研通 7782458
什么是DOI,文献DOI怎么找? 3434459
关于科研通互助平台的介绍 2558672
邀请新用户注册赠送积分活动 2481161